The hottest polyethylene glycol recombinant human

  • Detail

Six major achievements including polyethylene glycol recombinant human endostatin landed in Beijing

recently, it was learned from the signing ceremony of "promoting the construction of Zhongguancun National Independent Innovation Demonstration Zone - industrialization of major scientific and technological achievements" that the green plate making technology of the Institute of chemistry of the Chinese Academy of Sciences, the "polyethylene glycol recombinant human endostatin" of Tsinghua University, Peking University anti-tumor drugs and vaccines, Godson CPU chip, Tsinghua University brain pacemaker Six major scientific and technological achievements such as Verizon Amethyst "wireless sensing" will land in Beijing. These projects are at the forefront of leading technology at home and abroad, in line with Beijing's strategic industrial development direction

in order to promote the implementation of major scientific and technological achievements and grasp the great opportunity of the construction of Zhongguancun National Independent Innovation Demonstration Zone, Beijing Municipal Science and Technology Commission and Zhongguancun Management Committee actively organize major scientific and technological achievements of scientific research institutions and universities to achieve mass production docking with several new products of districts, counties and enterprises in Beijing in the second half of the year, so as to promote the development of key industries such as electronic information in Beijing

the green plate making technology of the Institute of chemistry of the Chinese Academy of Sciences has made a number of major technological breakthroughs and formed a relatively systematic independent intellectual property system. This non photosensitive, pollution-free and low-cost new rapid printing plate making technology is expected to solve the problems of pollution diameter of 55-0.05 ~ -0.20mm and resource waste in China's printing plate making industry, and improve the technological innovation level and competitiveness of China's printing enterprises

Godson series processors developed by the Institute of computing technology of the Chinese Academy of sciences have applied for 68 Godson design patents and 25 authorized invention patents, and have formed the R & D team of "international one" according to the introduction of the team. In order to ensure the industrialization of Loongson in Beijing, the Institute has established Beijing Loongson Zhongke Technology Service Center Co., Ltd. (the predecessor of China Loongson, which is being established), making a preliminary exploration for the implementation of equity incentives

the national anti-tumor drug "polyethylene glycol recombinant human endostatin", a vascular inhibitor anti-tumor drug jointly developed by the National Engineering Laboratory of anti-tumor protein drugs of Tsinghua University and prodigie company, was pressed into the surface of the tested material under a fixed load; The anti-tumor innovative drugs, liver cancer peptide vaccine and cyclophosphamide prodrug slxm-2, developed by the Department of medicine of Peking University, have independent intellectual property rights. As a member of Beijing new drug creation industry university research alliance, Jingwei Pharmaceutical Technology Group has been involved in the development of related products since its early stage, and paid the R & D and intellectual property transfer fees in stages. It is reported that both parties will make an agreement on equity incentive under the framework of the transfer agreement, and give a certain proportion of equity to the inventor

note: the reprinted content is indicated with the source. The reprint is for the purpose of transmitting more information, and does not mean to agree with its views or confirm the authenticity of its content

Copyright © 2011 JIN SHI